Compass Capital served as sole adviser on CDC’s strategic investment of EGP 1.885 billion in Alfa Medical Group, announced in February 2021.
The transaction brought growth capital to an integrated Egyptian healthcare group with diagnostic laboratories, radiology centres, and hospital operations. The investment was intended to support new hospitals and expand the group’s laboratory and scanning businesses.
Historical update · 3 February 2021
Original announcement